GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2026 8:51:50 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $274,410,000 +5,723.6% | Assets $1,146,551,000 | EPS $3.07 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/5/2026 4:39:58 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $274,410,000 +5,723.6% | Assets $1,146,551,000 | EPS $3.07 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/5/2026 4:35:20 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $213,475,000 +3,749.2% | Assets $885,544,000 | EPS $2.29 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/5/2026 4:25:17 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $213,475,000 +3,749.2% | Assets $885,544,000 | EPS $2.29 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/5/2026 4:33:24 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $56,368,000 +99.0% | Assets $697,459,000 | EPS $0.05 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/5/2026 4:11:44 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $56,368,000 +99.0% | Assets $697,459,000 | EPS $0.05 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/28/2026 4:53:36 PM | View | Proxy | SEC | Y 2025 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 2/25/2026 4:34:48 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $46,016,000 -89.4% | Assets $668,188,000 | EPS -$2.05 | |
| Protagonist Therapeutics, Inc (PTGX) | 2/25/2026 4:15:12 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $7,437,000 -95.6% | Assets $668,188,000 | EPS -$0.70 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2025 5:05:59 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $4,712,000 +0.8% | Assets $701,688,000 | EPS -$0.62 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2025 4:33:59 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $4,712,000 +0.8% | Assets $701,688,000 | EPS -$0.62 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/6/2025 4:34:13 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $5,546,000 +33.1% | Assets $718,006,000 | EPS -$0.55 | |
| Protagonist Therapeutics, Inc (PTGX) | 8/6/2025 4:14:31 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $5,546,000 +33.1% | Assets $718,006,000 | EPS -$0.55 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 5/6/2025 5:13:12 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $28,321,000 -88.9% | Assets $742,132,000 | EPS -$0.19 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/6/2025 4:38:44 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $28,321,000 -88.9% | Assets $742,132,000 | EPS -$0.19 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/29/2025 4:08:33 PM | View | Proxy | SEC | Y 2024 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 2/21/2025 4:44:37 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $434,433,000 +624.1% | Assets $744,725,000 | EPS $4.23 | |
| Protagonist Therapeutics, Inc (PTGX) | 2/21/2025 7:08:12 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $170,638,000 +184.4% | Assets $744,725,000 | EPS $2.01 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/7/2024 5:00:14 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $4,675,000 | Assets $603,857,000 | EPS -$0.54 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/7/2024 4:16:06 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $4,675,000 | Assets $603,857,000 | EPS -$0.54 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/6/2024 4:29:41 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $4,167,000 | Assets $614,629,000 | EPS -$0.50 | |
| Protagonist Therapeutics, Inc (PTGX) | 8/6/2024 7:10:12 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $4,167,000 | Assets $614,629,000 | EPS -$0.50 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 5/7/2024 5:05:41 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $254,953,000 | Assets $629,276,000 | EPS $3.26 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/7/2024 4:31:18 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $254,953,000 | Assets $629,276,000 | EPS $3.26 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/26/2024 5:02:03 PM | View | Proxy | SEC | Y 2023 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 2/27/2024 4:45:36 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $60,000,000 +125.7% | Assets $357,951,000 | EPS -$1.39 | |
| Protagonist Therapeutics, Inc (PTGX) | 2/27/2024 4:16:54 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $60,000,000 | Assets $357,951,000 | EPS $0.52 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/2/2023 5:19:04 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $330,016,000 | EPS -$0.58 | ||
| Protagonist Therapeutics, Inc (PTGX) | 11/2/2023 4:42:35 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $0 | Assets $330,016,000 | EPS -$0.58 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/3/2023 4:40:10 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $320,466,000 | EPS -$0.68 | ||
| Protagonist Therapeutics, Inc (PTGX) | 8/3/2023 4:26:06 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $0 | Assets $320,466,000 | EPS -$0.68 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 5/4/2023 4:54:21 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $239,858,000 | EPS -$0.67 | ||
| Protagonist Therapeutics, Inc (PTGX) | 5/4/2023 4:32:58 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $0 | Assets $239,858,000 | EPS -$0.67 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/12/2023 4:03:45 PM | View | Proxy | SEC | Y 2022 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 3/15/2023 4:59:43 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $26,581,000 -2.8% | Assets $247,928,000 | EPS -$2.60 | |
| Protagonist Therapeutics, Inc (PTGX) | 3/15/2023 4:12:44 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $0 | Assets $247,928,000 | EPS -$0.70 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/8/2022 5:07:46 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $282,174,000 | EPS -$0.64 | ||
| Protagonist Therapeutics, Inc (PTGX) | 11/8/2022 4:16:40 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $0 | Assets $282,174,000 | EPS -$0.64 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/4/2022 5:09:43 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $859,000 -62.1% | Assets $310,512,000 | EPS -$0.84 | |
| Protagonist Therapeutics, Inc (PTGX) | 8/4/2022 4:06:17 PM | View | Financials | Earnings | WIRE | 2Q 2022 | Rev $859,000 -62.1% | Assets $310,512,000 | EPS -$0.84 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 5/7/2022 9:40:56 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $25,722,000 +315.6% | Assets $348,296,000 | EPS -$0.43 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/4/2022 5:32:23 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $25,722,000 +315.6% | Assets $348,296,000 | EPS -$0.43 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/13/2022 5:08:47 PM | View | Proxy | SEC | Y 2021 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 2/28/2022 6:34:28 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $27,357,000 -4.4% | Assets $347,695,000 | EPS -$2.71 | |
| Protagonist Therapeutics, Inc (PTGX) | 2/28/2022 4:57:50 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $8,617,000 +52.5% | Assets $347,695,000 | EPS -$0.77 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/3/2021 5:22:10 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $10,286,000 -21.6% | Assets $373,175,000 | EPS -$0.70 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/3/2021 4:14:46 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $10,286,000 -21.6% | Assets $373,175,000 | EPS -$0.70 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/4/2021 4:54:31 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $2,265,000 -63.6% | Assets $404,232,000 | EPS -$0.69 | |
| Protagonist Therapeutics, Inc (PTGX) | 8/4/2021 4:18:08 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $2,265,000 -63.6% | Assets $404,232,000 | EPS -$0.69 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 5/4/2021 5:02:45 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $6,189,000 +69.7% | Assets $298,072,000 | EPS -$0.54 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/4/2021 4:09:43 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $6,189,000 +69.7% | Assets $298,072,000 | EPS -$0.54 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/14/2021 4:11:02 PM | View | Proxy | SEC | Y 2020 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 3/10/2021 4:42:20 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $28,628,000 +12,293.1% | Assets $324,468,000 | EPS -$1.92 | |
| Protagonist Therapeutics, Inc (PTGX) | 3/10/2021 4:09:34 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $5,650,000 +107.8% | Assets $324,468,000 | EPS -$0.47 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/4/2020 5:35:07 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $13,114,000 +216.7% | Assets $217,320,000 | EPS -$0.21 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/4/2020 5:14:38 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $13,114,000 +216.7% | Assets $217,320,000 | EPS -$0.21 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/6/2020 4:52:53 PM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $6,217,000 | Assets $224,980,000 | EPS -$0.59 | |
| Protagonist Therapeutics, Inc (PTGX) | 8/6/2020 4:09:49 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $6,217,000 | Assets $224,980,000 | EPS -$0.59 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 5/7/2020 5:24:30 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $3,647,000 +133.8% | Assets $134,901,000 | EPS -$0.72 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/7/2020 4:40:12 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $3,647,000 +133.8% | Assets $134,901,000 | EPS -$0.72 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/16/2020 5:29:34 PM | View | Proxy | SEC | Y 2019 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 3/10/2020 5:23:17 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $231,000 -99.3% | Assets $154,917,000 | EPS -$2.98 | |
| Protagonist Therapeutics, Inc (PTGX) | 3/10/2020 4:06:32 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $2,719,000 +15.6% | Assets $154,917,000 | EPS -$0.63 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2019 5:35:07 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $4,141,000 -32.3% | Assets $154,627,000 | EPS -$0.61 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2019 4:40:26 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $4,141,000 -32.3% | Assets $154,627,000 | EPS -$0.61 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/7/2019 5:34:12 PM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $148,105,000 | EPS -$1.18 | ||
| Protagonist Therapeutics, Inc (PTGX) | 8/7/2019 9:30:32 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev ($8,189,000) | Assets $148,105,000 | EPS -$1.18 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 5/8/2019 4:47:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $1,560,000 -85.5% | Assets $132,248,000 | EPS -$0.58 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/8/2019 7:09:48 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $1,560,000 -85.5% | Assets $132,248,000 | EPS -$0.58 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/26/2019 5:26:47 PM | View | Proxy | SEC | Y 2018 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 3/12/2019 5:13:58 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $30,925,000 +54.1% | Assets $139,472,000 | EPS -$1.74 | |
| Protagonist Therapeutics, Inc (PTGX) | 3/12/2019 4:09:33 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $2,353,000 -79.1% | Assets $139,472,000 | EPS -$0.57 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2018 5:03:37 PM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $6,117,000 -30.3% | Assets $148,856,000 | EPS -$0.38 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2018 4:33:54 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $6,117,000 -30.3% | Assets $148,856,000 | EPS -$0.38 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/7/2018 5:36:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $11,674,000 | Assets $137,473,000 | EPS -$0.41 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/9/2018 5:05:15 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $10,781,000 | Assets $149,239,000 | EPS -$0.36 | |
| Protagonist Therapeutics, Inc (PTGX) | 5/9/2018 4:29:17 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $10,781,000 | Assets $149,239,000 | EPS -$0.36 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 4/18/2018 4:06:38 PM | View | Proxy | SEC | Y 2017 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 3/7/2018 4:57:30 PM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $20,063,000 | Assets $163,734,000 | EPS -$2.09 | |
| Protagonist Therapeutics, Inc (PTGX) | 3/7/2018 4:09:46 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $11,282,000 | Assets $163,734,000 | EPS -$0.15 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 11/7/2017 6:13:51 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $8,781,000 | Assets $110,415,000 | EPS -$0.29 | |
| Protagonist Therapeutics, Inc (PTGX) | 11/6/2017 4:02:15 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $8,781,000 | Assets $110,415,000 | EPS -$0.29 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 8/8/2017 4:53:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $70,479,000 | EPS -$0.89 | ||
| Protagonist Therapeutics, Inc (PTGX) | 8/8/2017 4:23:28 PM | View | Financials | Earnings | SEC | 2Q 2017 | Assets $70,479,000 | EPS -$0.89 | Export Earnings Model | ||
| Protagonist Therapeutics, Inc (PTGX) | 5/10/2017 4:23:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $82,673,000 | EPS -$0.84 | ||
| Protagonist Therapeutics, Inc (PTGX) | 5/10/2017 4:07:33 PM | View | Financials | Earnings | SEC | 1Q 2017 | Assets $82,673,000 | EPS -$0.84 | Export Earnings Model | ||
| Protagonist Therapeutics, Inc (PTGX) | 4/24/2017 4:30:58 PM | View | Proxy | SEC | Y 2016 | ||||||
| Protagonist Therapeutics, Inc (PTGX) | 3/7/2017 4:51:08 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $93,990,000 | EPS -$5.80 | ||
| Protagonist Therapeutics, Inc (PTGX) | 3/7/2017 4:34:56 PM | View | Financials | Earnings | SEC | Y 2016 | Assets $93,990,000 | EPS -$0.67 | Export Earnings Model | ||
| Protagonist Therapeutics, Inc (PTGX) | 11/14/2016 5:39:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $102,843,000 | EPS -$0.87 | ||
| Protagonist Therapeutics, Inc (PTGX) | 11/14/2016 5:33:48 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $0 | Assets $102,843,000 | EPS -$0.87 | Export Earnings Model | |
| Protagonist Therapeutics, Inc (PTGX) | 9/15/2016 4:08:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $27,000 | Assets $24,516,000 | EPS -$19.07 |